Relationship between insulin sensitivity and the triglyceride-HDL-C ratio in overweight and obese postmenopausal women: A MONET study

Applied Physiology, Nutrition and Metabolism

Volumn 32, Issue 6, 2007, Pages 1089-1096

  Karelis, Antony D ^a   Pasternyk, Stephanie M ^b   Messier, Lyne ^b   St Pierre, David H ^b   Lavoie, Jean Marc ^c   Garrel, Dominique ^b   Rabasa Lhoret, Rémi ^b  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Blood lipids; HOMA; Hyperinsulinemic euglycemic clamp; Muscle strength; Visceral fat

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ANAEROBIC THRESHOLD; ARTICLE; BLOOD; BODY COMPOSITION; COMPUTER ASSISTED TOMOGRAPHY; CROSS-SECTIONAL STUDY; DIET; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; MUSCLE STRENGTH; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTMENOPAUSE; RISK FACTOR;

ADULT; AGED; ANAEROBIC THRESHOLD; BLOOD GLUCOSE; BODY COMPOSITION; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; DIET; FEMALE; GLUCOSE CLAMP TECHNIQUE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; MIDDLE AGED; MUSCLE STRENGTH; OBESITY; OVERWEIGHT; POSTMENOPAUSE; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TRIGLYCERIDES;

EID: 39049168603     PISSN: 17155312     EISSN: None     Source Type: Journal    
DOI: 10.1139/H07-095     Document Type: Article

References (28)

1. Abbasi, F., Brown, B.W., Jr., Lamendola, C., McLaughlin, T., and Reaven, G.M. 2002. Relationship between obesity, insulin resistance, and coronary heart disease risk. J. Am. Coll. Cardiol. 40: 937-943. doi:10.1016/S0735- 1097(02)02051-X.
2. Brehm, A., Pfeiler, G., Pacini, G., Vierhapper, H., and Roden, M. 2004. Relationship between serum lipoprotein ratios and insulin resistance in obesity. Clin. Chem. 50: 2316-2322. doi:10.1373/clinchem.2004.037556.
3. Brochu, M., Poehlman, E.T., and Ades, P.A. 2000. Obesity, body fat distribution, and coronary artery disease. J. Cardiopulm. Rehabil. 20: 96-108. doi:10.1097/00008483-200003000-00003.
4. Carnethon, M.R., Gulati, M., and Greenland, P. 2005. Prevalence and cardiovascular disease correlates of low cardiorespiratory fitness in adolescents and adults. JAMA, 294: 2981-2988. doi:10.1001/jama.294.23. 2981.
5. DeFronzo, R.A., Tobin, J.D., and Andres, R. 1979. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 237: E214-E223.
6. Friedewald, W.T., Levy, R.I., and Fredrickson, D.S. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18: 499-502.
7. Gastaldelli, A., Miyazaki, Y., Pettiti, M., Matsuda, M., Mahankali, S., Santini, E., et al. 2002. Metabolic effects of visceral fat accumulation in type 2 diabetes. J. Clin. Endocrinol. Metab. 87: 5098-5103. doi:10.1210/jc.2002-020696.
8. Gaziano, J.M., Hennekens, C.H., O'Donnell, C.J., Breslow, J.L., and Buring, J.E. 1997. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation, 96: 2520-2525.
9. Grundy, S.M., Cleeman, J.I., Daniels, S.R., Donato, K.A., Eckel, R.H., Franklin, B.A., et al. 2005. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 112: 2735-2752. doi:10.1161/ CIRCULATIONAHA.105.169404.
10. Haffner, S.M., Stern, M.P., Hazuda, H.P., Mitchell, B.D., and Patterson, J.K. 1990. Cardiovascular risk factors in confirmed pre-diabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA, 263: 2893-2898. doi:10.1001/jama.263.21.2893.
11. Hanley, A.J., Karter, A.J., Festa, A., D'Agostino, R., Jr., Wagenknecht, L.E., Savage, P., et al. 2002. Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis Study. Diabetes, 51: 2642-2647. doi:10.2337/diabetes.51.8.2642.
12. Ingelsson, E., Sundstrom, J., Arnlov, J., Zethelius, B., and Lind, L. 2005. Insulin resistance and risk of congestive heart failure. JAMA, 294: 334-341. doi:10.1001/jama.294.3.334.
13. Jeppesen, J., Hein, H.O., Suadicani, P., and Gyntelberg, F. 1998. Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation, 97: 1029-1036.
14. Jurca, R., Lamonte, M.J., Church, T.S., Earnest, C.P., Fitzgerald, S.J., Barlow, C.E., et al. 2004. Associations of muscle strength and fitness with metabolic syndrome in men. Med. Sci. Sports Exerc. 36: 1301-1307. doi:10.1249/01.MSS.0000135780.88930.A9.
15. Katzmarzyk, P.T., Church, T.S., Janssen, I., Ross, R., and Blair, S.N. 2005. Metabolic syndrome, obesity, and mortality: impact of cardiorespiratory fitness. Diabetes Care, 28: 391-397. doi:10.2337/diacare.28.2.391.
16. Lee, S., Kuk, J.L., Katzmarzyk, P.T., Blair, S.N., Church, T.S., and Ross, R. 2005. Cardiorespiratory fitness attenuates metabolic risk independent of abdominal subcutaneous and visceral fat in men. Diabetes Care, 28: 895-901. doi:10.2337/diacare.28.4.895.
17. Lewis, G.F., Carpentier, A., Adeli, K., and Giacca, A. 2002. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr. Rev. 23: 201-229. doi:10.1210/er.23.2.201.
18. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., and Turner, R.C. 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28: 412-419. doi:10.1007/BF00280883.
19. McLaughlin, T., Abbasi, F., Cheal, K., Chu, J., Lamendola, C., and Reaven, G. 2003. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann. Intern. Med. 139: 802-809.
20. McLaughlin, T., Reaven, G., Abbasi, F., Lamendola, C., Saad, M., Waters, D., et al. 2005. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am. J. Cardiol. 96: 399-404. doi:10.1016/j.amjcard.2005.03.085.
21. Metter, E.J., Talbot, L.A., Schrager, M., and Conwit, R. 2002. Skeletal muscle strength as a predictor of all-cause mortality in healthy men. J. Gerontol. A Biol. Sci. Med. Sci. 57: B359-B365.
22. Rantanen, T., Harris, T., Leveille, S.G., Visser, M., Foley, D., Masaki, K., et al. 2000. Muscle strength and body mass index as long-term predictors of mortality in initially healthy men. J. Gerontol. A Biol. Sci. Med. Sci. 55: M168-M173.
23. Reaven, G.M. 1988. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes, 37: 1595-1607. doi:10.2337/diabetes.37.12.1595.
24. Sayer, A.A., Dennison, E.M., Syddall, H.E., Gilbody, H.J., Phillips, D.I., and Cooper, C. 2005. Type 2 diabetes, muscle strength, and impaired physical function: the tip of the iceberg? Diabetes Care, 28: 2541-2542. doi:10.2337/diacare.28.10.2541.
25. Wagenknecht, L.E., Langefeld, C.D., Scherzinger, A.L., Norris, J.M., Haffner, S.M., Saad, M.F., et al. 2003. Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes, 52: 2490-2496. doi:10.2337/diabetes.52.10.2490.
26. Wallace, T.M., Levy, J.C., and Matthews, D.R. 2004. Use and abuse of HOMA modeling. Diabetes Care, 27: 1487-1495. doi:10.2337/diacare.27.6.1487.
27. Wathan, D. 1994. Essentials of strength training and conditioning. Human Kinetics, Champaign, Ill.
28. Young, J.C. 1995. Exercise prescription for individuals with metabolic disorders. Practical considerations. Sports Med. 19: 43-54.